A growing number of global pharmaceutical companies are deploying SharePoint as the means to manage teams and projects. Microsoft reports the following as SharePoint adopters:
Companies cite two principal reasons for adoption: one the need for a flexible platform that provides a basis for ad hoc collaboration of project teams without the intervention of IT, and two, the need to consolidate the plethora of legacy systems acquired over decades, which are expensive to maintain. For example, Bill Louv, CIO of GlaxoSmithKline notes that
“GlaxoSmithKline has more than 100,000 employees, hundreds of business partners, and locations around the world, so effective collaboration is critical to our business.”
And Karen M Shegda from Gartner (Research Note G00163873) notes that
“Pfizer had to accommodate highly regulated documents and records, but it also needed a way to support the more ad hoc and collaborative processes.” Pfizer consolidated some 125+ different document management systems to operate as One Pfizer. “By standardizing on two platforms (Documentum and SharePoint) for clearly delineated tasks, it can eliminate servers and support for legacy systems.”
A surprising element of these deployment decisions, is that some companies, notably Novartis and GSK, have elected to deploy SharePoint as a service hosted outside of their firewall (Business Productivity Online Suite [BPOS], Microsoft Online Services ). The idea of placing the management of the “crown jewels” of a pharmaceutical company, its intellectual property, into the hands of a third party outside of the firewall would have been considered pure heresy just a few years ago. The change of attitude reflects the fact that security risks inside and outside of the firewall have achieved parity and the fact that the new needs of large pharmaceutical companies drive changes. In the words of pharmaceutical executives:
“We have chosen Microsoft Online Services because it promises to deliver a simple intuitive Information Workspace that should not only value to the company through simplification, but provide an improved experience and ultimately create a more productive GSK.” Bill Louv, CIO, GlaxoSmithKline
“We chose Microsoft Online Online Services for our collaboration applications in the cloud for our 100,000 employees around the world. It will enable our large research and development population to better collaborate to innovate. We can trust Microsoft to provide the enterprise capabilities our company requires to further improve personal productivity and collaboration among our associates so we can focus on our core mission–improving the lives of patients worldwide.” Leon V. Schumacher, Group CIO of Novartis
“The move to Microsoft Online Services will help GlaxoSmithKline cut operational costs by an estimated 30 percent.” Ingo Elfering, VP of Information Technology Strategy, GlaxoSmithKline
